Chun Wel Lin

769 total citations
25 papers, 567 citations indexed

About

Chun Wel Lin is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Oncology. According to data from OpenAlex, Chun Wel Lin has authored 25 papers receiving a total of 567 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 10 papers in Cellular and Molecular Neuroscience and 7 papers in Oncology. Recurrent topics in Chun Wel Lin's work include Receptor Mechanisms and Signaling (10 papers), Neuropeptides and Animal Physiology (7 papers) and Estrogen and related hormone effects (5 papers). Chun Wel Lin is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Neuropeptides and Animal Physiology (7 papers) and Estrogen and related hormone effects (5 papers). Chun Wel Lin collaborates with scholars based in United States, United Kingdom and Finland. Chun Wel Lin's co-authors include Michael A. Stashko, Kazumi Shiosaki, Curtis M. Tyree, John K. Pratt, Steven W. Elmore, Michael J. Coghlan, Benjamin C. Lane, Peer B. Jacobson, Denise M. Wilcox and Donald R. Britton and has published in prestigious journals such as Biochemistry, Brain Research and Journal of Medicinal Chemistry.

In The Last Decade

Chun Wel Lin

24 papers receiving 546 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chun Wel Lin United States 13 183 178 123 123 103 25 567
Loan Miller United States 15 211 1.2× 173 1.0× 145 1.2× 100 0.8× 77 0.7× 23 709
Yoshio Ogino Japan 16 314 1.7× 137 0.8× 143 1.2× 216 1.8× 204 2.0× 42 836
Peter Lockey United Kingdom 18 385 2.1× 214 1.2× 64 0.5× 96 0.8× 113 1.1× 34 876
Erika A. Currier United States 17 469 2.6× 127 0.7× 335 2.7× 65 0.5× 80 0.8× 26 851
Tomohiro Kaku Japan 12 152 0.8× 89 0.5× 86 0.7× 140 1.1× 113 1.1× 23 566
Christopher S. Konkoy United States 16 386 2.1× 170 1.0× 260 2.1× 246 2.0× 28 0.3× 23 888
Wilfried Hornberger Germany 16 249 1.4× 203 1.1× 83 0.7× 32 0.3× 25 0.2× 36 599
Bumsup Lee United States 14 283 1.5× 57 0.3× 97 0.8× 184 1.5× 55 0.5× 21 603
Dieter Seidelmann Germany 6 189 1.0× 100 0.6× 190 1.5× 82 0.7× 15 0.1× 10 499
Shubin Sheng United States 10 398 2.2× 179 1.0× 48 0.4× 185 1.5× 601 5.8× 11 992

Countries citing papers authored by Chun Wel Lin

Since Specialization
Citations

This map shows the geographic impact of Chun Wel Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun Wel Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun Wel Lin more than expected).

Fields of papers citing papers by Chun Wel Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun Wel Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun Wel Lin. The network helps show where Chun Wel Lin may publish in the future.

Co-authorship network of co-authors of Chun Wel Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Chun Wel Lin. A scholar is included among the top collaborators of Chun Wel Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chun Wel Lin. Chun Wel Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Bo, Mei Liu, Zhili Xin, et al.. (2006). Optimization of 2,4-diaminopyrimidines as GHS-R antagonists: Side chain exploration. Bioorganic & Medicinal Chemistry Letters. 16(7). 1864–1868. 11 indexed citations
2.
McNally, Teresa, Terry M. Pederson, Stevan W. Djurić, et al.. (2004). Cloning and characterization of the glucagon receptor from cynomologous monkey. Peptides. 25(7). 1171–1178.
3.
Elmore, Steven W., John K. Pratt, Michael J. Coghlan, et al.. (2004). Differentiation of in vitro transcriptional repression and activation profiles of selective glucocorticoid modulators. Bioorganic & Medicinal Chemistry Letters. 14(7). 1721–1727. 41 indexed citations
4.
Kurukulasuriya, Ravi, Bryan K. Sorensen, J. T. Link, et al.. (2004). Biaryl amide glucagon receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 14(9). 2047–2050. 21 indexed citations
5.
Groebe, Duncan R., Terry M. Pederson, Jill E. Clampit, et al.. (2003). Putting Thought to Paper: A μARCS Protease Screen. SLAS DISCOVERY. 8(6). 668–675. 4 indexed citations
6.
Kym, Philip R., Michael E. Kort, Michael J. Coghlan, et al.. (2003). Nonsteroidal Selective Glucocorticoid Modulators:  The Effect of C-10 Substitution on Receptor Selectivity and Functional Potency of 5-Allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines. Journal of Medicinal Chemistry. 46(6). 1016–1030. 86 indexed citations
8.
Elmore, Steven W., Michael J. Coghlan, David D. Anderson, et al.. (2001). Nonsteroidal Selective Glucocorticoid Modulators:  the Effect of C-5 Alkyl Substitution on the Transcriptional Activation/Repression Profile of 2,5-Dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines. Journal of Medicinal Chemistry. 44(25). 4481–4491. 94 indexed citations
9.
Shen, Yong, et al.. (1998). Induced expression of neuronal membrane attack complex and cell death by Alzheimer's β-amyloid peptide. Brain Research. 796(1-2). 187–197. 38 indexed citations
10.
Shiosaki, Kazumi, Chun Wel Lin, Hana Kopecka, et al.. (1997). Minor Structural Differences in Boc-CCK-4 Derivatives Dictate Affinity and Selectivity for CCK-A and CCK-B Receptors. Journal of Medicinal Chemistry. 40(7). 1169–1172. 2 indexed citations
11.
Wu‐Wong, Jinshyun R., William J. Chiou, Scott R. Magnuson, Bruce R. Bianchi, & Chun Wel Lin. (1996). Human astrocytoma U138MG cells express predominantly type-A endothelin receptor. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1311(3). 155–163. 14 indexed citations
13.
Holladay, Mark W., Michael J. Bennett, James F. Kerwin, et al.. (1995). Amino acid-derived piperidides as novel CCKB ligands with anxiolytic-like properties. Bioorganic & Medicinal Chemistry Letters. 5(24). 3057–3062. 5 indexed citations
14.
Elliott, Richard L., Hana Kopecka, Michael J. Bennett, et al.. (1994). Tetrapeptide CCK agonists: structure-activity studies on modifications at the N-terminus. Journal of Medicinal Chemistry. 37(2). 309–313. 9 indexed citations
15.
Shue, Youe‐Kong, Michael D. Tufano, George M. Carrera, et al.. (1993). Double bond isosteres of the peptide bond: Synthesis and biological activity of cholecystokinin (CCK) C-terminal hexapeptide analogs. Bioorganic & Medicinal Chemistry. 1(3). 161–171. 6 indexed citations
16.
Miller, Thomas R., et al.. (1993). Peripheral cholecystokinin type A receptors mediate oxytocin secretion in vivo. Regulatory Peptides. 43(1-2). 107–112. 10 indexed citations
17.
Witte, David G., Alex M. Nadzan, Jean Martínez, Marc Rodriguez, & Chun Wel Lin. (1992). Characterization of the novel CCK analogs JMV-180, JMV-320, and JMV-332 in H345 cells. Peptides. 13(6). 1227–1232. 13 indexed citations
18.
Shiosaki, Kazumi, Chun Wel Lin, Hana Kopecka, et al.. (1992). Development of potent and selective CCK-A receptor agonists from Boc-CCK-4: tetrapeptides containing Lys(N.epsilon.)-amide residues. Journal of Medicinal Chemistry. 35(11). 2007–2014. 6 indexed citations
19.
Kerwin, James F., Alex M. Nadzan, Hana Kopecka, et al.. (1989). Hybrid cholecystokinin (CCK) antagonists: new implications in the design and modification of CCK antagonists. Journal of Medicinal Chemistry. 32(4). 739–742. 25 indexed citations
20.
Lin, Chun Wel, Saul Maayani, & Sherwin Wilk. (1981). [3H]Dihydroergocryptine binding to bovine striatal membranes defined by a low d-butaclamol concentration. Biochemical Pharmacology. 30(11). 1305–1314. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026